Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV

Bioorganic & Medicinal Chemistry Letters
2017.0

Abstract

Novel (non-fluoroquinolone) inhibitors of bacterial type II topoisomerases (NBTIs) are an emerging class of antibacterial agents. We report an optimized series of cyclobutylaryl-substituted NBTIs. Compound 14 demonstrated excellent activity both in vitro (S. aureus MIC90=0.125μg/mL) and in vivo (systemic and tissue infections). Enhanced inhibition of Topoisomerase IV correlated with improved activity in S. aureus strains with mutations conferring resistance to NBTIs. Compound 14 also displayed an improved hERG IC50 of 85.9μM and a favorable profile in the anesthetized guinea pig model.

Knowledge Graph

Similar Paper

Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Bioorganic & Medicinal Chemistry Letters 2017.0
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel bacterial topoisomerase inhibitors derived from isomannide
European Journal of Medicinal Chemistry 2020.0
Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity
Journal of Medicinal Chemistry 2013.0
Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK<sub>a</sub>: Antibacterial Agents with an Improved Safety Profile
Journal of Medicinal Chemistry 2012.0
Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing
ACS Medicinal Chemistry Letters 2014.0
Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria
Journal of Medicinal Chemistry 2021.0
Discovery and structure–activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2022.0
Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus
ACS Medicinal Chemistry Letters 2020.0